Early results show benefit of remdesivir for COVID-19

Early clinical trial results support the use of remdesivir for patients with severe COVID-19 who require supplemental oxygen, but more research is needed to improve outcomes for people with COVID-19.
Source: NIH Research Matters - Category: Research Source Type: news